CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY
https://doi.org/10.20996/1819-6446-2008-4-5-34-38
Abstract
Therapy of arterial hypertension in patients with overweight and obesity has peculiarities. Reasons for comparable study of efficacy and safety of therapies based on β-blockers (carvedilol and metoprolol) in this type of patients are presented. Study aims and design, efficacy and safety criteria are described.
About the Authors
S. Y. Martsevich
State Research Center of Preventive Medicine of Rosmedtechnology, Petroverigsky per. 10, Moscow, 101990 Russia
Russian Federation
on behalf of working group on CAMELLIA trial
Russian Federation
on behalf of working group on CAMELLIA trial
N. P. Kutishenko
State Research Center of Preventive Medicine of Rosmedtechnology, Petroverigsky per. 10, Moscow, 101990 Russia
Russian Federation
on behalf of working group on CAMELLIA trial
Russian Federation
on behalf of working group on CAMELLIA trial
References
1. WHO. Obesity preventing and managing the global epidemic. WHO Consultation on Obesity, Geneva, 3-5 June 1997. Geneva: WHO; 1997.
2. Must A, Spadano J, Coakley EH, Field AE at al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9.
3. Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V. Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int J Obes 2002;26:48- 57.
4. Wofford MR, Anderson DC Jr, Brown CA, Jones DW at al. Antihypertensive effect of alfa- and beta-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens 2001;14:694-8.
5. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87.
6. Sharma AM, Pischon T, Hardt S, Kunz I at al. Hypothesis: beta-adrenergic receptor blockades and weight gain: a systematic analysis. Hypertension 2001;37:250-4.
7. Bakris G.L., Fonseca V., Katholi R.E., et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 2004:292:2227–36.
8. С.А. Шальнова, С.Ю. Марцевич, А.Д. Деев, и др. Первые результаты многоцентрового рандомизированного клинического исследования по применению препарата Акридилол в комбинированной терапии у больных артериальной гипертонией и ожирением или сахарным диабетом 2-го типа (АККОРД). Кардиология 2008;(8):28-33.
Review
For citations:
Martsevich S.Y., Kutishenko N.P. CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. Rational Pharmacotherapy in Cardiology. 2008;4(5):34-38. (In Russ.) https://doi.org/10.20996/1819-6446-2008-4-5-34-38
Views:
680
Email this article 